FABP2 and hepatocellular carcinoma: For example, FABP2 is highly expressed in gastric cancer [13], whereas high FABP3 expression has been associated with poor prognosis in patients with hepatocellular carcinoma (HCC) [14, 15] and esophageal cancer [16, 17].